CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016

CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three and nine months ended September 30, 2016 after market close on Wednesday, November 2, 2016. CombiMatrix management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss those results and answer questions.

Live Call:	U.S.:	(866) 634-2258
	International:	(330) 863-3454

Live Webcast:	http://edge.media-server.com/m/p/moipsncy
	The webcast replay will be archived for 30 days

Replay:	U.S.:	(855) 859-2056
	International:	(404) 537-3406
	Passcode:	93599356
	The telephone replay will be available for seven days

About CombiMatrix Corporation

CombiMatrix Corporation provides best-in-class molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic diagnostics and screening, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. Our testing focuses on advanced technologies, including single nucleotide polymorphism (“SNP”) chromosomal microarray analysis (“CMA”), next generation sequencing (“NGS”), fluorescent in situ hybridization (“FISH”) and high resolution karyotyping. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.